- Changing Patterns of Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer Disease
-
Rhie SY, Kim JG
- KMID: 937939
- Korean J Gastroenterol.
- 2007 Dec;50(6):407-409.
No abstract availble. -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Anti-secretory Treatment in Addition to Helicobacter pylori Eradication Triple Therapy in the Treatment of Peptic Ulcer
-
Jung JM, Shim KN, Oh HJ, Na YJ, Jung HS, Jung SA, Yoo K
- KMID: 782957
- Korean J Gastroenterol.
- 2008 Jan;51(1):11-18.
BACKGROUND/AIMS: It is not clear whether the anti-secretory therapy should be continued for symptomatic relief and ulcer healing before or after the eradication of H. pylori in patients with peptic... -
- CITED
-
- Close
- SHARE
-
- Close
- Guidelines of Treatment for Non-bleeding Peptic Ulcer Disease
-
Cheung DY, Jung HY, Song HJ, Jung SW, Jung HC, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association of Gastroenterology
- KMID: 1767732
- Korean J Gastroenterol.
- 2009 Nov;54(5):285-297.
- doi: 10.4166/kjg.2009.54.5.285
Over the past century, since the introduction of non steroidal anti-inflammatory drugs (NSAID), antacid, histamine H2-receptor antagonists (H2RA), proton pump inhibitors (PPI), and discovery of Helicobacter pylori infection, the paradigm... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Acid Pump Antagonist (Revaprazan, Revanex(R)) on the Result of 13C Urea Breath Test in the Patients with Helicobacter pylori Associated Peptic Ulcer Disease
-
Park SY
- KMID: 991460
- Korean J Gastroenterol.
- 2011 Jan;57(1):1-2.
- doi: 10.4166/kjg.2011.57.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Use of Proton Pump Inhibitors in Gastrointestinal Diseases
-
Rew JS
- KMID: 1113451
- Korean J Gastroenterol.
- 2006 Mar;47(3):181-190.
The development and introduction into clinical practice of proton pump inhibitors (PPIs) have influenced the management of acid-peptic disorders dramatically. PPIs inhibit the gastric hydrogen/potassium adenosine triphosphatase selectively and irreversibly... -
- CITED
-
- Close
- SHARE
-
- Close
- A Prospective Study on Rabeprazole-based Triple Therapy for Helicobacter pylori Eradication in Patients with Peptic Ulcer
-
Choi BK, Yang SY, Park ET, Jang YS, Lee YJ, Lee SH, Seol SY, Chung JM
- KMID: 772530
- Korean J Gastroenterol.
- 2003 Aug;42(2):102-107.
BACKGROUND/AIMS: Rabeprazole sodium is a potent proton pump inhibitor. We assessed the efficacy, safety and compliance of one-week triple therapy including rabeprazole with amoxicillin and clarithromycin for eradication of... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Helicobacter pylori Eradication Rate in Patients with Non-ulcer Dyspepsia and Peptic Ulcer Diseases according to Proton Pump Inhibitors
-
Hong EJ, Park DI, Oh SJ, Song MJ, Choi WH, Hong CH, Park JH, Kim HJ, Cho YK, Shon CI, Jeon WK, Kim BI
- KMID: 783038
- Korean J Gastroenterol.
- 2008 Aug;52(2):80-85.
BACKGROUND/AIMS: Conflicting results have been reported whether patients with non-ulcer dyspepsia (NUD) respond differently to Helicobacter pylori (H. pylori) eradication treatment compared with patients with peptic ulcer diseases (PUD). The... -
- CITED
-
- Close
- SHARE
-
- Close
- Changing Patterns of Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer Disease
-
Bang SY, Han DS, Eun CS, Kim JE, Ahn SB, Sohn JH, Jeon YC, Kang JO
- KMID: 937930
- Korean J Gastroenterol.
- 2007 Dec;50(6):356-362.
BACKGROUND/AIMS: Antibiotic resistance of Helicobacter pylori (H. pylori) is a significant clinical problem because it reduces the efficacy of eradication therapy. The aims of this study were to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
-
Lim JH, Kim SG, Song JH, Hwang JJ, Lee DH, Han JP, Hong SJ, Kim JH, Jeon SW, Kim GH, Shim KN, Shin WG, Kim TH, Kim SM, Chung IK, Kim HS, Kim HU, Lee J, Kim JG
- KMID: 2412188
- Gut Liver.
- 2017 Mar;11(2):226-231.
- doi: 10.5009/gnl16099
BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease. METHODS: Between 2002 and 2014,... -
- CITED
-
- Close
- SHARE
-
- Close
- Retreatment of Helicobacter pylori Infection with Triple Therapy after Initial Treatment Failure
-
Kim N, Lim SH, Lee KH, Koo MS, Kim JM, Hwang JH, Kim JW, Lee DH, Jung HC, Song IS
- KMID: 881583
- Korean J Gastroenterol.
- 2003 Sep;42(3):195-203.
BACKGROUND/AIMS: Helicobacter pylori (H. pylori) treatments fail at least in 10-20% of patients. However, retreatment strategies after failure of initial treatment have not been established. This study was conducted to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Acid Pump Antagonist (Revaprazan, Revanex(R)) on Result of 13C Urea Breath Test in Patients with Helicobacter pylori Associated Peptic Ulcer Disease
-
Oak JH, Chung WC, Jung SH, Choi KH, Kim EJ, Kang BK, Kang B, Kong SE, Paik CN, Lee KM
- KMID: 991462
- Korean J Gastroenterol.
- 2011 Jan;57(1):8-13.
- doi: 10.4166/kjg.2011.57.1.8
BACKGROUND/AIMS: Revaprazan (Revanex(R)) is a novel proton pump inhibitor (PPI) that has a somewhat different effect on proton pump compared with the other PPI's, also (called as 'acid pump antagonist').... -
- CITED
-
- Close
- SHARE
-
- Close
